Effect of metformin on survival outcomes in diabetic patients with triple receptor‐negative breast cancer

Soley Bayraktar, Leonel F. Hernadez‐Aya, Xiudong Lei, +5

Cancer

Primary angiosarcomas of the breast

Taimur Sher, Bryan T. Hennessy, Vicente Valero, +6

Cancer

Low locoregional failure rates in selected breast cancer patients with tumor‐positive sentinel lymph nodes who do not undergo completion axillary dissection

Rosa F. Hwang, Ana M. Gonzalez‐Angulo, Min Yi, +7

Cancer

Utility of oncotype DX risk estimates in clinically intermediate risk hormone receptor‐positive, HER2‐normal, grade II, lymph node‐negative breast cancers

Catherine M. Kelly, Savitri Krishnamurthy, Giampaolo Bianchini, +4

Cancer

Women age ≤ 35 years with primary breast carcinoma

Ana M. Gonzalez‐Angulo, Kristine Broglio, Shu‐Wan Kau, +7

Cancer

Incidence of brain metastases as a first site of recurrence among women with triple receptor–negative breast cancer

Shaheenah Dawood, Xiudong Lei, Jennifer K. Litton, +3

Cancer

Earlier age of onset of <i>BRCA</i> mutation‐related cancers in subsequent generations

Jennifer K. Litton, Kaylene Ready, Huiqin Chen, +8

Cancer

Efficacy of neoadjuvant therapy with trastuzumab concurrent with anthracycline‐ and nonanthracycline‐based regimens for HER2‐positive breast cancer

Soley Bayraktar, Ana M. Gonzalez‐Angulo, Xiudong Lei, +7

Cancer

Efficacy and safety of neoadjuvant trastuzumab combined with paclitaxel and epirubicin

Shaheenah Dawood, Ana M. Gonzalez‐Angulo, Florentia Peintinger, +6

Cancer

Central nervous system metastases in patients with high‐risk breast carcinoma after multimodality treatment

Ana M. Gonzalez‐Angulo, Massimo Cristofanilli, Eric A. Strom, +5

Cancer